Form 4 Filing for Kevin Waters

Kevin Waters, EVP, CFO of PROCEPT BioRobotics Corp, acquired 29,527 shares of Common Stock on August 13, 2026. This acquisition was part of a grant of restricted stock units (RSUs), with vesting occurring over time subject to continued service. Additionally, Waters received a stock option to purchase 40,851 shares of Common Stock, also with a vesting schedule tied to continued employment. These grants are intended to partially replace his expected 2027 grant. Following these transactions, Waters directly owns 180,728 shares of Common Stock and holds options for 40,851 shares.